Top 50 Life Science VC (Venture Capital) Funds in Middle East in May 2025
A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Middle east. We rank investors based on the number of investments they made in Life science companies from Middle east. We update this investor list every month.Top 50 Life Science VC (Venture Capital) Funds in Middle East in May 2025
Early Stage Investment Fund and Network
Show more
Investment focus
- Biotechnology, Energy, Manufacturing
- Seed, Pre-Seed, Angel
- Turkey, United States, Estonia
Portfolio highlights
- & New Me — Explore the best aesthetic treatments in Turkey with New Me. Book a consultation, read reviews, and find the right doctor for your beauty journey.
- Winfluencer — Winfluencer is a platform for automated digital influencer marketing. Their solutions are machine learning, augmented reality, image processing, data analytics, social media analytics, and fraud detection. Winfluencer connects thousands of e-commerce sites through a single platform and an automated system. Because of the new generation affiliatemarketing approach, this system enables users to generate long-term income. Its transparent structure allows both users and the e-commerce site to track sales generated by their interactions.
- Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies.
Our golden eggs
Ayana Pharma
A late stage company with
Show more
Investment focus
- Biotechnology, Pharmaceutical, Life Science
- Seed, Series B, Series F
- Israel
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Early Stage VC
Show more
Investment focus
- Software, Biotechnology, Machine Learning
- Seed, Pre-Seed, Series A
- Israel, United States, United Kingdom
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators.
The firm was founded in 2017 and is based in Columbia.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Seed, Pre-Seed, Series A
- Egypt, United States, The Netherlands
Portfolio highlights
- Educatly — We help you get into the University of your dreams. We are the only platform with all the information you need to Study Abroad
- InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
- Synapse Analytics — We build data science and AI solutions for streamlined operations and data driven decisions. Synapse Analytics, enabling a smarter world.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- RayThera — RayThera specializes in developing breakthrough small molecule therapies for critical unmet needs in immunology. Backed by decades of drug discovery expertise, we accelerate the development process while maintaining rigorous standards.
- Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
- Edgewise Therapeutics — See how we bring our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Grant, Seed, Pre-Seed
- Israel, United States, Mali
Portfolio highlights
- i-EcoGuard — I-Ecoguard is pioneering sustainable agriculture with cutting-edge nanoparticle technology. Our objective is to improve greenhouse efficiency, plant health, and crop quality.
- Eretz Angels — Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.
- Lowental Hybrid — Lowental Hybrid technology combines fuel-based propulsion with electric power, enabling longer operating hours while preserving the low noise levels characteristic of electric systems.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series A, Series B, Series C
- Israel, United States, China
Portfolio highlights
- Finout — Finout provides DevOps, FinOps, and Finance a self-service cloud cost management tool that provides unmatched business context into their cloud environment
- Somite — Somite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies.
- Perfect — A personalized talent-finding and engaging experience made for every team.
Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients.
The company was founded by Ross Barrett.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Seed, Series A
- Israel, United States, Germany
Portfolio highlights
- Eisbach Bio — Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes. Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors. It is founded in 2019 and is based in Martinsried, Bavaria.
- March Biosciences — Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity
- Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more
Investment focus
- Software, Artificial Intelligence, Aerospace
- Seed, Funding Round, Series A
- Israel, United Kingdom, Estonia
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Oryx Fund is a MENA-focused Investment fund from Hambro Perks. Investing in game-changing early-stage technology companies at late Seed and Series A, led by outstanding entrepreneurs in sectors we have deep expertise such as Fintech, Healthtech, Enterprise tech, Logistics tech, and Edtech.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Series A
- United Arab Emirates, Saudi Arabia, Egypt
Portfolio highlights
- Ejari — Ejari is providing a Rent Now, Pay Later (RNPL) solution for residential rentals, Rent Now, Pay Later products enable tenants to better manage their budgets by converting rent from a yearly expense to a monthly expense, while landlords receive an entire year's rent in advance.
- Growdash — Growdash is a business intelligence and analytics tool built specifically for restaurants to support profitable growth strategic decisions across online sales channels.
- Merit Incentives — Seamless, API-driven solutions connecting you to a global network of 7,000+ brands, enabling real-time, instant gratification across 155+ countries.
Averroes Ventures helps and invests in entrepreneurial teams seeking to transform big ideas into game-changing companies. Averroes Ventures' team possesses years of combined experience in global business operation and management across a multitude of sectors to help achieve visions.
Show more
Investment focus
- Transportation, Logistics, Delivery
- Seed, Convertible Note
- Egypt, United Arab Emirates
Portfolio highlights
- ILLA — Digital trucking and delivery platform powered by reliable drive to enable businesses with different volumes handle and optimize their trucking and logisitcs processes effeciently.
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
- Khazenly — Khazenly is an on-demand digital warehousing and fulfillment management platform that provides an omnichannel solution to help merchants digitize their businesses.
Healthcare innovation wherever it originates.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Israel, United Kingdom
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
- Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........
Show more
Investment focus
- FinTech, Financial Services, Software
- Seed, Pre-Seed, Series A
- Nigeria, United States, Egypt
Portfolio highlights
- Mtor — Mtor is an online marketplace that is reshaping the automotive aftermarket and provides sophisticated technology solutions.
- EMTECH — EMTECH provides solutions for Digital Currency regulatory compliance, development and management to help Central Banks and FinTechs build, run and manage modern financial systems.
- Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.
aMoon is a leading healthtech & life sciences venture capital firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Funding Round
- United States, Israel, Switzerland
Portfolio highlights
- Lyfegen — Lyfegen is the first of its kind, a company making value-based healthcare contracting for high-cost therapies a reality for all healthcare stakeholders.
- Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
- MetaSight Diagnostics — MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more
Investment focus
- Biotechnology, Life Science, Biopharma
- Seed, Funding Round
- Israel
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
Investing with conviction in visionary, technical founders inventing the future.
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Pre-Seed, Series A
- United States, Canada, Israel
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
- Phaseshift Technologies — Phaseshift Technologies is developing a Computational Materials Engineering (CME) platform to help accelerate the Research and Development of High-Performance Alloys. The CME platform is driven by Quantum Chemistry calculations and aided by Machine Learning based predictive algorithms.
Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.
Show more
Investment focus
- Health Care, Biotechnology, Life Science
- Series A, Series B, Funding Round
- Israel, United States, Malaysia
Portfolio highlights
- NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
Minrav provides engineering and construction services.
Show more
Investment focus
- Health Care, Hospital, Wellness
- Series A, Funding Round
- Israel, Malaysia
Portfolio highlights
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
- Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.
PeakBridge is a global impact VC that funds and connects the people, technology and processes that will shape the future of food.
Show more
Investment focus
- Food and Beverage, Food Processing, Health Care
- Series A, Seed, Funding Round
- Israel, United States, United Kingdom
Portfolio highlights
- BE WTR — The first premium sustainable water brand aiming to promote a more ecological water consumption and to contribute to a better hydration thanks to its technological and design water systems. | Discover more about us.
- Mondra — AI-driven environmental insights platform that supports food system players to accelerate Scope 3 progress, reduce the cost of Net Zero, and drive competitive advantage.
- Orbisk — One-third of all food produced (worldwide) is wasted. Orbisk helps professional kitchens to get a grip on their food waste.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Software
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.
Show more
Investment focus
- Manufacturing, Construction, Health Care
- Private Equity, Debt Financing, Funding Round
- United States, Israel
Portfolio highlights
- The Good Feet Store — Discover comfort and foot pain relief with The Good Feet Store arch support inserts. Clinically proven - improve body alignment and overall foot health.
- WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
- Conditioned Air — Trust Conditioned Air for expert HVAC services in Southwest Florida. We offer AC repair, replacement, heating solutions, and indoor air quality services.
Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Seed, Series A, Series B
- Egypt, United States, United Kingdom
Portfolio highlights
- Pyka — We believe that electrification and automation will make aviation safer, more affordable, and more accessible than has ever been possible in human history.
- ShopLook — Online personal styling destination. Discover outfit ideas or virtually create your own using our outfit maker.
- Cash Cows — Cash Cows helps startups hone their operations and strategies so they can expand profitably and create better brands. They collaborate with customers to close the gap between traditional business practices (experience) and cutting-edge approaches (solutions), allowing companies to operate successfully.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio.
It's never too early to have a conversation about your startup.
Show more
Investment focus
- Health Care, FinTech, E-Learning
- Seed, Pre-Seed, Series A
- Israel, United States, Norway
Portfolio highlights
- Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
- Vayu — Discover Vayu, the cutting-edge billing and revenue management platform designed to streamline operations and maximize efficiency for finance teams.
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.
Show more
Investment focus
- E-Commerce, Mobile, Marketplace
- Seed, Angel, Pre-Seed
- Egypt, United States, Lebanon
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
- Sprints — home page Description
- The Fashion Kingdom — Fashion, Sneakers for men, women, and kids
The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.
Show more
Investment focus
- Life Science, Organic Food, Biotechnology
- Series A
- Israel
Portfolio highlights
- BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
Based out of Dubai, Knuru pursues equity and credit opportunities in fintech and marketplaces across the GCC, Africa and Southern Europe. The management is led by a team of investors and entrepreneurs bringing to venture capital extensive cross-asset class experience dedicated to supporting high growth businesses.
Show more
Investment focus
- E-Commerce, Information Technology, Financial Services
- Series A, Funding Round, Series C
- United Arab Emirates, Spain, Kenya
Portfolio highlights
- Savana — Transform EMR into Deep-Real World Evidence with a scientific methodology that applies Artificial Intelligence (AI) to EMR free-text.
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
- The Giving Movement — Sustainable Activewear & Streetwear Clothing | Made in UAE | $4 per item donated to charity | Gym Clothing & Workout Clothes
Fark Labs is a global innovation and transformation hub that aims to build a better future for all. We help entrepreneurs, startups, corporations, and investors transform into more connected, innovative, and future-ready versions of themselves so they have a positive impact on the world. We apply an investment portfolio approach to our innovationstrategy, touching all stages of the startup lifecycle from incubator to investor in Turkey, which is strengthened by our strong global network of regional accelerators and VC partners in our key global geographies. We use this approach for our 4 focus verticals: mobility, life sciences, sustainable lifestyle, and emerging technologies, which we call our curiosity cabinet.We back change-makers who transform industries and create new ones. Our sweet spot is investing early, and we continue to provide support and investment up to Series A. We envision a better future by championing entrepreneurship, innovation, and frontier technologies that transform legacy businesses and build future-proof startups.We also drive innovation and transformation through collaborative intelligence. We build a unique ecosystem that connects difference-makers, leading corporations, venture capital firms, universities, and government agencies across our 4 verticals.
Show more
Investment focus
- SaaS, Manufacturing, Last Mile Transportation
- Seed, Series A, Pre-Seed
- Turkey
Portfolio highlights
- M-Based — M-based is an initiative aiming to develop eco-friendly alternative material technologies using mycelium, a component of the mushroom. Its R&D efforts focus on developing mycelium-based vegan leather to address environmental concerns and animal ethics violations in the textile industry.
- MaestroHub — MaestroHub is a Single Source of Truth industrial data governance platform to overcome data architecture and integration challenges faced in digital transformation. MaestroHub points data sources to a smart data layer with drag & drop features and automatically creates contextualized data packages in real-time with Unified Namespacearchitecture. MaestroHub is the first self-diagnostic Unified Namespace solution with DataOps capabilities.
- Ion Membranes — Ion membranes is a company that designs and manufactures ion exchange membranes and separators for the green energy industry. Our products are used in batteries, electrolyzers, fuel cells, chlor-alkali facilities, electrodialysis water treatment processes, and other applications that require ionic range separation.
Impacting the future of medicine.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
- Bicycle Therapeutics — Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
- Progentos Therapeutics — Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
Khwarizmi Ventures is a venture capital firm that seeks investments in startups with a passion for algorithms. It seeks to help create their vision, as they embark on a journey together that aligns their goals to improve quality of life using technology powered by algorithms.
.
Show more
Investment focus
- E-Commerce, Software, FinTech
- Seed, Series A, Pre-Seed
- Saudi Arabia, United Arab Emirates, Egypt
Portfolio highlights
- Erad — erad provides growth capital to online businesses. Connect your analytics and receive funding offers, for non-dilutive capital within 48 hours
- Khazna — Khazna is an Egyptian company that aims to improve and expand financial services for Egyptians through the mobile application.
- Aya — Aya is a modest fashion e-commerce platform that strives to unite the fragmented modest fashion industry into a single discovery platform.
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more
Investment focus
- Health Care, Medical, Artificial Intelligence
- Series A, Series B, Seed
- United States, Israel, Ghana
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
RMGP Biopharma Investment Fund is an investment Fund
Show more
Investment focus
- Biotechnology, Biopharma, Health Care
- Seed, Series B, Funding Round
- Israel
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
financial holding company / investments
Show more
Investment focus
- FinTech, Finance, Payments
- Seed, Pre-Seed
- The Netherlands, Israel
Portfolio highlights
- Wakuli — It's called specialty coffee. Roasted lighter to enhance all the exciting flavours. To really taste them it's important to drink fresh. That's why we send our mailbox-friendly coffee within one week after roasting. And always with a better price for the farmers - thanks to you.
- Diptera — Developing technology to fight mosquitoes with mosquitoes.
- Flow — Flow is FinTech 3.0: It let's you automate payments between your bank accounts and wallets. Based on triggers and actions you can transfer your money automatically to the accounts you choose. Use Flow to automate a budgetting system, your investing, buying crypto or to distribute your money the way you like it. Where the previous generationpayment companies needed to build and maintain expensive payment rails, Flow focusses on leveraging Open Banking. People trust Flow to help with their cashflow automation.
JVP is a top VC firm with $1.9B AUM and 165 companies built, leading in AI, Cyber Security, Fintech, Insurtech and Climatech.
Show more
Investment focus
- Software, Cyber Security, Enterprise Software
- Series A, Series B, Seed
- United States, Israel, United Kingdom
Portfolio highlights
- Datricks — Offering real-time risk detection and control, ensuring continuous financial compliance and enabling you to significantly impact the bottom line of your business
- Greeneye Technology — Spray Less, Grow More. Our mission is to dramatically reduce chemicals usage while increasing productivity and profitability for farmers.
- Secret Double Octopus — Provider of industry-leading FIDO-certified, rotation-based passwordless MFA with the fullest support for enterprise complexity. Click here for more!
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
RM Global is an investment banking and strategic advisory firm dedicated to creating unique value for its clients and investors. We specialize in Life Sciences, including pharmaceuticals, medical devices, biotechnology, healthcare IT/digital health, and diagnostics. Our broad international reach includes the Americas, Europe, Israel, and Asia.Since 1992, our diverse team of accomplished professionals has worked closely with life science companies ranging from start-ups to multinationals, providing unbiased strategic and financial advice, based upon our comprehensive industry experience. Several of our partners were senior management of Roberts Mitani, which completed over $3 billion in M&A and strategic transactions and raised over $200 million in private growth and venture capital for clients. We take pride in our long term relationships with our clients that span many years.We leverage our unique global network of leading corporations, investment funds, institutional and strategic investors, family offices, industry experts and management teams to source and execute transactions that build new opportunities for our clients worldwide.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B
- Israel, United States
Portfolio highlights
- BIOMx — Developing natural and engineered phage therapies to eradicate harmful bacteria in chronic diseases.
- Mitoconix Bio — Mitoconix Bio is pioneering a disease-modifying strategy of improving mitochondrial functions for treating neurodegenerative diseases.Mitochondria generates ATP, the energy source for all cellular activities. Mitochondria are also involved in other essential cellular functions, including calcium sequestration, amino acid and lipid metabolism,keeping balanced redox potential and orchestrating programmed cell death. In neurons in particular, mitochondria are very dynamic organelles that constantly undergo fission (division) and fusion. This process, called mitochondrial dynamics, is critical in maintaining healthy and functional mitochondria under both normal conditions and in response to stress and in ensuring having viable mitochondria along the axons and in the synaptic boutons. A defect in either fusion or fission limits mitochondrial motility, decreases energy production, increases oxidative stress and activates pro-apoptotic signaling thereby promoting cell dysfunction and death.Mitoconix’ lead drug is a first-in-class inhibitor of pathological mitochondrial fragmentation and dysfunction with demonstrated in vivo efficacy in animal models of Huntington’s (HD) and Parkinson’s diseases (PD) and beneficial activity in patient-derived cells of HD, sporadic and genetic PD, and sporadic and genetic Alzheimer’s disease (AD).
- ImmPACT Bio — ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.
Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series C, Post-IPO Equity
- United States, United Kingdom, France
Portfolio highlights
- CurvaFix — Curvafix is the only intramedullary implant that follows the natural curvature of the pelvis. Continue reading to learn how the Curvafix implant works!
- Boundless Bio — Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.Boundless Bio was founded in 2018 and isheadquartered in La Jolla, California.
- LENZ Therapeutics — LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision.
Backing a better tomorrow
Show more
Investment focus
- Renewable Energy, Software, Biotechnology
- Series A, Seed, Series B
- Australia, United States, Singapore
Portfolio highlights
- Gridmo — gridmo accelerates the connection of generation to the grid. Unlock access to fast and accurate power system studies.
- Endolith — Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition.
- Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Switzerland, United Kingdom
Portfolio highlights
- CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
- BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Series B
- Israel
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- Israel, United States, Switzerland
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Honeycomb — Honeycomb (fka Agilius) is the only place where you can buy a condo/apartment building master policy online in less than 3 minutes at a fraction of the cost! Instant, free, no hassle quotes, online everything and up to 40% savings. With all that we're bringing simplicity and transparency to the real estate insurance space for condoassociations (HOAs), building owners, property managers, and developers everywhere. This is what we do. This is all we do.
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Talisman Capital Partners operates as a private investment company.
Show more
Investment focus
- Information Services, Pet, News
- Series A, Seed, Series B
- United States, Israel, Hong Kong
Portfolio highlights
- Bond Vet — We offer compassionate, thorough, & friendly pet care in a warm, comfortable environment. Walk in or book online.
- Prilenia — Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.The company wasfounded in 2018 and is based in Israel, the Netherlands, and Boston.
- qServe Communications — At qServe Communications, it is their unique vision to be a one-stop source for all your maintenance and development needs. They understand the difficulty of locating reliable companies to meet all of your infrastructure requirements. qServe has built an answer to this problem, a national service network of in-house employees to deliver qualitymanagement, installation, erection, inspection and maintenance services to the communications industry.With their full spectrum of project and program management services, they drive your project from start to finish, becoming an integral part of your development team. Many of qServe Communications crews and staff bring many years of valuable experience in the development of communications systems and infrastructures. From Program and Project Management to in-house installation and maintenance services, qServe will work diligently to ensure your project's success.qServe has performed thousands of projects for clients including: AT&T Wireless Services, Alltel Mobile, Nextel, Sprint, Omnipoint, Bell Atlantic Mobile, Teligent, Metricom, American Tower, Crown Castle and SBA Communications Corporation.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Venture Capital Firm
Show more
Investment focus
- FinTech, Health Care, Life Science
- Pre-Seed, Series A
- United Arab Emirates
Portfolio highlights
- InvestSky — InvestSky offers zero commission investing in your favorite stocks. Invest smarter, together. Trading mobile app is coming soon, join the waitlist!
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
TPY Capital is a Tel Aviv based early state VC, investing in some of Israel’s most talented entrepreneurs. They are active investors who typically lead rounds in the areas we invest in, which include data and analytics, digitization and human augmentation, fintech, and frontier tech such as quantum computing.
Show more
Investment focus
- Software, Artificial Intelligence, Big Data
- Seed, Series A, Series B
- Israel, United States, France
Portfolio highlights
- Tabnine — Tabnine is an AI code-completion tool that helps developers worldwide write better code faster.
- Kodem Security — Providing users with runtime intelligence to grasp the relevant application risks.
- DOT Compliance — Harness the power of the AI-powered solution built for quality and compliance in life sciences. Get a demo of Dot Compliance.
Alex Angels is an investment management company that helps investors to invest in early-stage companies with strong management teams. The company specializes in the fields of financial services, financial exchange, and investments.
Alex Angels was founded in 2016 and headquartered in Al Iskandariyah, Egypt.
Show more
Investment focus
- E-Commerce, Marketplace, Mobile Apps
- Seed, Pre-Seed, Convertible Note
- Egypt
Portfolio highlights
- CardoO — Welcome To Our InnovationsExplore
- SIDEUP — SIDEUP provides you with all the necessary tools to grow your business through a hassle-free experience from local and global logistics support, storage services, and innovative and real-time dashboards.
- Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, China, United Kingdom
Portfolio highlights
- GaeaStar — The zero waste clay cup. GaeaStar is an engineering company developing sustainable multiple use products and technology.
- CairnSurgical — CairnSurgical is developing innovative patient-specific tools to guide surgical interventions for patients with cancer.
- Epigenic Therapeutics — Epigenic Therapeutics is a biotech firm that offers gene editing therapy.
Hult Alumni Angels
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Seed
- Egypt
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Investors by industry
Impact
Biotech
Gaming
FinTech
Google
Energy
Proptech
Marketplace
Consumer
Hardware
Artificial intelligence
Health Care
Climate
Community
EdTech
Sustainability
Venture Capital
Clean Energy
Real Estate
Financial Services
Video Games
B2B
Education
Publishing
Finance
Food and Beverage
Beauty
Infrastructure
Web3
Photography
Retail
Big Data
Organic Food
Payments
Social Media
Medical
Internet
Manufacturing
eSports
Construction
Digital Media
Art
Local
Sports
Music
Enterprise Software
Social Network
Wellness
Email
Franchise
Android
Mobile
Legal
Mobile Advertising
Platforms
Cannabis
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Automotive
Medical Device
Social
Crowdfunding
Wine And Spirits
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Film
Life Science
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Germany
India
United States
Ireland
South Korea
Canada
Australia
New Zealand
Middle East
Oceania
Europe
Asia
South Africa
Armenia
Brazil
Qatar
Indonesia
Spain
China
Saudi Arabia
Sri Lanka
Vietnam
Africa
LATAM
Japan
Singapore
Finland
Estonia
Hungary
Ethiopia
Hong Kong
Georgia
Egypt
Ecuador
Denmark
France
Faroe Islands
Ghana
Croatia
Gibraltar
Bulgaria
Chile
Belize
Barbados
Costa Rica
Greece
Belgium
Bahrain
Belarus
Bermuda
Czech Republic
Algeria
Mali
Mexico
Liberia
Israel
Philippines
Malaysia
Italy
Lithuania
Liechtenstein
Kuwait
Norway
Morocco
Myanmar
Lebanon
Mauritius
Peru
Jersey
Panama
Malta
Nicaragua
Sweden
El Salvador
Uruguay
Portugal
Zambia
Ukraine
Uzbekistan
Senegal
Seychelles
Venezuela
Tajikistan
Taiwan
Serbia
Uganda
Dominican Republic
Sierra Leone
Turkey
Thailand
Azerbaijan
Nigeria
Bahamas
Namibia
Iceland
Iraq
United Arab Emirates
Tunisia
Jamaica
San Marino
Rwanda
Puerto Rico
Honduras
Poland
Isle of Man
Bolivia
Russian Federation
Luxembourg
Tanzania
Albania
Pakistan
Slovenia
Zimbabwe
Togo
Grenada
Romania
Jordan
Argentina
Bangladesh
Kenya
Kazakhstan
Cayman Islands
Cambodia
Colombia
Oman
Cyprus
Latvia
Austria
Cameroon
Switzerland
Guatemala
Marshall Islands
VC (Venture Capital) Funds in Middle East by industry
Restaurants
Crowdfunding
Venture Capital
Real Estate
Financial Services
Cryptocurrency
Education
Finance
Payments
Video Games
Medical
Wellness
Food and Beverage
Medical Device
Non Profit
Biotechnology
Social Media
Manufacturing
Art
Digital Media
Android
Mobile
Blockchain
Local
Legal
Construction
Google
Software
eSports
Theatre
Fitness
Automotive
Hospitality
InsurTech
Cannabis
FinTech
Enterprise
Consumer
Music
Biotech
Climate
EdTech
Sustainability
Energy
SaaS
Proptech
Marketplace
Hardware
Transportation
Film
Social
Retail
Web3
Infrastructure
Fashion
Beauty
B2B
Life Science
Publishing
Photography
Big Data
Clean Energy
Oil and Gas
Renewable Energy
Recruiting
Email
Social Network
Platforms
Mobile Advertising
Internet
Mobile Apps
Gaming
Travel
Facebook
Agriculture (agtech)
Media (entertainment)
Machine Learning
Health Care
Enterprise Software
Organic Food
Sports
CleanTech
Social Impact
Impact
Artificial intelligence
Community